Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Tumor Boards
Colleague Insights
Living Resources
Conferences
Video Expert Opinion
Round Table Discussions
Sign in
Join now

In an effort to better serve our users, we have streamlined our content offering. As a result, we no longer publish new content or update existing content in Advanced Prostate Cancer. Visit the 'Content & Subscriptions' tab of your Settings page at any time to update your Dashboard or Newsletter Subscription preferences to continue to see news and information that interests you most.

featured
Published in Advanced Prostate Cancer

Expert Opinion / Cases · June 22, 2022

68-Year-Old Man With mCRPC Who Progressed Post Docetaxel and Abiraterone Acetate

Pedro Barata MD

 

 Save  Recommend
 Share

Discuss This item Follow

No comments yet, be the first to start the discussion!

  • Noureddine Benjaafar

    Jun 23, 2022

    OLAPARIB 300MGbid

  • Charles Maack

    Jun 23, 2022

    start Lu177-PSMA-617 (assuming it is available at your Institution)
  • Comment deleted by Moderator.

  • Bernard Riley

    Jun 24, 2022

    Olaparib
  • Comment deleted by Moderator.

  • nadire kucukoztas

    Jun 24, 2022

    start olaparib 300mg BID

  • Andrea Sporchia

    Jun 24, 2022

    start olaparib 300mg BID

  • alice goodman

    Jun 24, 2022

    Start olaparib

  • Samaneh Sarbaz

    Jun 24, 2022

    Cabazitaxel

  • Philip von Lintel MD

    Jun 24, 2022

    I agree with Charles  Maack  ; To theoretically approach specific mets and nondetectable micromets ;; perhaps less toxicity

  • Shusit Parnitvitidkun

    Jun 25, 2022

    Start olaparib
  • Comment deleted by Moderator.

  • Javier  Cassinello

    Jul 16, 2022

    OLAPARIB ( we have a biomarker)

  • Angela Tiganas

    Jul 16, 2022

    4

  • Namita Vinayek

    Jul 17, 2022

    Olaparib

  • Philip von Lintel MD

    Jul 18, 2022

    in addition  to the Lu 177 PSMA ( +/-)    Radioguided surgery , MRI guided focused ultrasound (MRI )  ; for applicable targets ;  Consider adequate additional support / appropriate use of ? metformin , HIIT ( physical conditioning )  ,  diet , probiotics ... every little bit !

  • juliana chaves

    Feb 26, 2023

    start olaparib 300mg BID

  • Franz Stoiber

    Feb 27, 2023

    Prior Olaparib, then go for Lu just to maintain his haematological reserve as long as possible
but check performance for delivering Cabazitaxel as long or soon as it possible

  • Jan 29, 2025

    Pending Moderator approval.
    Delete

Further Reading

Recently Updated